We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Study Probes Role of Sestrin 3 in Glucose Metabolism and Diabetes Development

By LabMedica International staff writers
Posted on 18 Nov 2014
A recent paper discussed the role of sestrin proteins in resisting oxidative stress and regulating metabolic processes such as glucose production and insulin sensitivity, which are disrupted in type II diabetes and metabolic syndrome.

Investigators at Indiana University School of Medicine (Indianapolis, USA) focused their attention on the protein Sestrin 3 (Sesn3). More...
The gene for this protein in humans is located on chromosome 11q21. The sestrin family of proteins, of which Sesn3 is a member, comprises cysteine sulfinyl reductases, and they modulate peroxide signaling and antioxidant defense. These proteins selectively reduce or repair hyperoxidized forms of typical 2-cysteine peroxiredoxins (enzymes that metabolize peroxides) in eukaryotes.

Sestrin expression was found to be regulated by the tumor suppressor protein p53. Sesn3 was identified as a forkhead box O (FoxO) protein with antioxidant activity. Recently it was reported that Sesn3 may play an important role in Akt induced increase in reactive oxygen species (ROS), and it might be a promising target in selectively killing cancer cells containing high levels of Akt activity.

Akt, also known as protein kinase B (PKB), is a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. Akt is hyperactivated in cancer. This hyperactivity leads to an increase in intracellular ROS mainly by inhibiting the expression of ROS scavengers downstream of FoxO, such as Sesn3.

In the current study, the investigators generated Sesn3 liver-specific transgenic and knockout mice. These animals were fed a diet with 18% of its calories from fat or a high-fat diet with 60% of calories from fat.

Results published in the November 5, 2014, online edition of the journal Diabetes revealed that mice lacking Sesn3 had elevated fasting blood glucose levels, indicative of impaired liver insulin sensitivity or poorly regulated glucose metabolism. Insulin and glucose tolerance tests were significantly improved in Sesn3-positive control mice.

Biochemical analysis revealed that Sesn3 interacted with and activated mTORC2 (mechanistic target of rapamycin complex 2) and subsequently stimulated Akt phosphorylation at serine 473. These findings suggested that Sesn3 could activate Akt via mTORC2 to regulate liver insulin sensitivity and glucose metabolism.

Senior author Dr. X. Charlie Dong, associate professor of biochemistry and molecular biology at the Indiana University School of Medicine, said, "We wanted to show that Sestrin 3 had critical liver-specific functions. This is a very fascinating protein. It is not very big, but it functions in a very dynamic manner controlling glucose production and insulin sensitivity. It is an important regulator for glucose homeostasis."

Related Links:

Indiana University School of Medicine



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.